Skip to main content

Table 1 Clinicopathological parameters included in risk models for solitary fibrous tumor

From: Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index

Variable

Patients, n (%)

5-year MFS (%)

(95% CI)

Log-rank

p value

Age (years)

 < 55 (score 0)

19 (44.2)

100 (a)

0.218

 ≥ 55 (score 1)

24 (55.8)

87.2 (60.2–96.8)

 

Sex

 Male

21 (48.8)

85.6 (56.1–96.5)

0.121

 Female

22 (51.2)

100 (a)

 

Location

 IT

10 (23.3)

100 (a)

0.229

 IA

12 (27.9)

87.5 (46.3–98.3)

 

 CNS

6 (14.0)

100 (a)

 

 Other

15 (34.9)

88.9 (50.0–98.5)

 

Tumor size (cm)

 0–4.9 (score 0)

24 (55.8)

100 (a)

0.095

 5–9.9 (score 1)

10 (23.3)

100 (a)

 

 10–14.9 (score 2)

3 (7.0)

100 (a)

 

 ≥ 15 (score 3)

6 (14.9)

60.0 (20.0–90.0)

 

Mitoses/mm2

 0 (score 0)

34 (79.1)

94.7 (70.6–99.3)

0.982

 0.5–1.5 (score 1)

4 (9.3)

100 (a)

 

 ≥ 2 (score 2)

5 (11.6)

66.7 (15.4–95.7)

 

Ki-67 LI (%)

 < 1 (score 0)

15 (34.9)

90.0 (53.3–98.6)

0.018

 1–10 (score 1)

24 (55.8)

100 (a)

 

 ≥ 10 (score 2)

4 (9.3)

50.0 (5.8–94.1)

 

Tumor necrosis (%)

 < 10 (score 0)

40 (93.0)

92.3 (73.5–98.1)

0.978

 ≥ 10 (score 1)

3 (7.0)

100 (a)

 

Dedifferentiation

 Present

2 (4.7)

0

0.000

 Absent

41 (95.3)

95.7 (74.8–99.4)

 

Three-variable risk model (age, size, mitoses)

 Low (0–2 points)

33 (76.7)

100 (a)

0.049

 Intermediate (3–4 points)

7 (16.3)

50.0 (5.9–94.1)

 

 High (5–6 points)

3 (7.0)

66.7 (15.4–95.7)

 

Four-variable risk model (age, size, mitoses, necrosis)

 Low (0–3 points)

37 (86.0)

100 (a)

0.060

 Intermediate (4–5 points)

4 (9.3)

50.0 (5.9–94.1)

 

  High (6–7 points)

2 (4.7)

50.0 (5.9–94.1)

 

Modified three-variable model (age, size, Ki-67 LI)

 Low risk (0–2 points)

29 (67.4)

100 (a)

0.006

  Intermediate/high risk (3–6 points)

14 (32.6)

74.1 (35.6–93.7)

 

Modified four-variable model (age, size, Ki-67 LI, necrosis)

 Low risk (0–3 points)

35 (81.4)

100 (a)

0.022

 Intermediate/high risk (4–7 points)

8 (18.6)

62.5 (21.9–90.9)

 
  1. CI confidence interval, CNS central nervous system, IA intra-abdominal, IT intrathoracic, LI labeling index, MFS metastasis-free survival
  2. a95% CI was not calculated because of no events until 5 years